- In February 2023 , Vetoquinol introduces Lygoferrin, a scientifically formulated, natural immunity booster designed to strengthen defense mechanisms in animals. This innovative product enhances resistance against infections by supporting the body's innate immune response. Lygoferrin helps reduce dependency on antibiotics, promoting overall health and well-being in livestock and companion animals. Its advanced formula ensures rapid absorption and effective protection, minimizing the risk of bacterial and viral infections. With this launch, Vetoquinol reinforces its commitment to sustainable animal health solutions, providing veterinarians and farmers with a reliable, natural alternative to enhance immunity and improve productivity in animal care
- In February 2023, Vetoquinol introduces Immun-C Aqua, an advanced water-soluble immune booster designed to enhance the health and resilience of aquatic species. This innovative formula strengthens disease resistance, improves overall vitality, and optimizes growth performance in fish and shrimp farming. By fortifying the immune system, Immun-C Aqua helps reduce mortality rates and enhances survival in challenging environments. With a scientifically developed composition, it ensures rapid absorption and effective action, contributing to sustainable and productive aquaculture. This launch underscores Vetoquinol’s commitment to providing high-quality, research-backed solutions for the aquaculture industry, supporting healthier aquatic livestock and improving farm profitability
- In January 2025 , Laurie Hueneke Martens, Associate VP of North America Public Policy and Government Relations at Merck Animal Health, received the 8th Annual Feather in Her Cap Award. Recognized for her leadership in public policy and mentoring future women leaders, Hueneke also saw a USD 5,000 donation made to her chosen animal charities
- In February 2024, Merck Animal Health announced that the European Commission has granted marketing authorization for BRAVECTO TriUNO, a new chewable tablet for dogs. This product targets both internal and external parasites, offering protection against fleas, ticks, gastrointestinal nematodes, heartworm, and angiostrongylosis. It is now approved in multiple countries, including Peru and Costa Rica
- In November 2024, Merck Animal Health announced the winners of the 2024 High-Quality Pork Pignnovation Award. Romain Delcombel of BioAZ won Champion, with Joao Lopes of Redsoft Technologica LTDA as Runner-Up and Jaap de Wit of Westfort in third. The awards recognize their innovative contributions to swine industry advancements in health, welfare, and sustainability
